SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

US Cancer Clinics Scramble to Get Experimental Revolution Medicines Pancreatic Cancer Drug

U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines while they await...

Implanted Islet Cell Device Could Control Glucose for Weeks

Researchers developed a battery-free device the size of a coin that can deliver islet cells in the body and keep them healthy, no immunosuppression required.

Blame for the Obesity Epidemic Falls on Food Industry

The rise of new weight-loss drugs could help reframe obesity as a societal failure driven by the food industry, rather than an individual failing rooted in lack of willpower.

Can GLP-1 Drugs Improve Breast Cancer Survival?

A ‘big’ data study links the diabetes and weight-loss drugs to better long-term survival after breast cancer. Critics are unconvinced.

EyePoint's Late-stage Eye Drug Trials to Continue After Safety Panel Review

EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials ⁠of its experimental eye disease drug Duravyu and recommended the...

Can Gut Bacterium Supplement Lead to Less Weight Regain?

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines while they await...

Researchers developed a battery-free device the size of a coin that can deliver islet cells in the body and keep them healthy, no immunosuppression required.

The rise of new weight-loss drugs could help reframe obesity as a societal failure driven by the food industry, rather than an individual failing rooted in lack of willpower.

A ‘big’ data study links the diabetes and weight-loss drugs to better long-term survival after breast cancer. Critics are unconvinced.

EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials ⁠of its experimental eye disease drug Duravyu and recommended the...

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

News All Time

Hidden Sugar Traps Patients With Diabetes Should Recognize

Food labels are often misleading when it comes to glycemic impacts.

Oral Orforglipron Effective in Older Adults With Obesity

People over 65 taking once-daily oral orforglipron achieved substantial weight loss with a consistent safety profile, regardless of T2D status, in a post hoc ATTAIN trial analysis.

Refining Management Strategies for Patients With Endometriosis

Refining Management Strategies for Patients With Endometriosis

Toddler Has Menstrual Cycle at 17 Months

Clinicians ruled out precocious puberty before landing on a diagnosis of exclusion

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Accurate and Timely Diagnosis of Endometriosis

Accurate and Timely Diagnosis of Endometriosis

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Many Older Patients Can Ditch Common Thyroid Drug, Study Suggests

Experts call for better guidance on levothyroxine initiation, deprescribing

GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics

News and commentary from the endocrinology world

Further Doubt on Heart-Healthiness of Calcium Supplements

Recurrent cardiovascular events increased in a large cohort study

Drug Manufacturer Coupon Use; Cholesterol Targets for Secondary Prevention

Also in TTHealthWatch: deprescribing levothyroxine

Are GLP-1 Drugs Linked to Erectile Dysfunction?

Real-world study in type 2 diabetes suggests possible association, but more research is needed

Call to Integrate Obesity Management With Surgery, GLP-1s Into Cancer Care

"Most effective therapies" underutilized, say authors, but oncologist cites lack of quality data

Recommended News For You

In breast cancer patients with nodes positive, preoperative hydroxyprogesterone may enhance disease-free survival.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

Clinical trial sees dramatic results using radiation to treat breast cancer

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

Study: For predicting breast cancer, AI performs better than traditional risk models.

Q&A: How early cancer screening could save Canada nearly half a billion dollars over patients' lifetimes

Conditional EU Nod for Weekly Pill in Pediatric Glioma

Recommended Articles For You

Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates 

Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools 

Case Study: Genomic Medicine in Precision Oncology 

How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More People Than Previously Believed Have Schizophrenia.

2.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

3.

Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.

4.

Including Bereavement in the Care Continuum.

5.

Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.

1.

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis

2.

Exploring the Potential of Bendamustine in Cancer Treatment

3.

Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data

4.

Neutrophil Profiling and AI Rewrites Cancer Diagnosis

5.

Everything You Need to Know About CA 19-9 and Cancer Diagnosis

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

4.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot